Navigation Links
Celebrity Golf Classic raises $553,443 for Seena Magowitz Foundation
Date:2/27/2012

e powerful ally than Roger Magowitz, whose own commitment has initiated many incredible partnerships within the home furnishings industry," Bassoff said. "We also are extremely grateful to have merited the support of Steve Stagner and the Mattress Firm."

In March 2011, Mattress Firm announced that it named TGen its "charitable partner of choice," specifically funding TGen's pancreatic cancer research.

In May 2011, Mattress Firm kicked off their fundraising efforts for TGen's pancreatic cancer clinical trials.

In December 2011, pancreatic clinical trials began through TGen and other sites that are named for Seena Magowitz.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Plastic Surgeons Rate Auction of World-Class Florida Laterra Spa May 21 a Perfect 10, Great Business Opp for Celebrity Retreat
2. New source of classical techniques for blood-based studies in the laboratory mouse
3. Editor of Springer classic human genetics reference receives prize
4. Study pinpoints genetic variation that raises a risk linked to bisphosphonates
5. Crowdfunding science: Student raises cash online to follow a flying fox
6. Paternity of subordinates raises cooperative effort in cichlids
7. Fading ability to taste iron raises health concerns for people over age 50
8. Extreme weight gain raises risk for recurrence among breast cancer survivors
9. Missing sugar molecule raises diabetes risk in humans
10. FASEB praises President Obama for increasing funding for research in his FY 2012 budget
11. New UCLA study raises questions about genetic testing of newborns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... In the cover story for the journal ... at the University of Massachusetts Amherst describe a new ... study the function of individual proteins in individual cell ... should allow deeper insights into protein function, Chase says, ... what that single protein does when we isolate its ...
(Date:6/19/2013)... International Science Consortium (PISC) is extremely disappointed that ... has upheld a decision that requires Dow Benelux ... rats. The study will use approximately 1160 animals ... to the substance dipropylene glycol methyl ether acetate ... Community,s Regulation on the Registration, Evaluation, Authorisation and ...
(Date:6/19/2013)... Diversity Course at the Marine Biological Laboratory (MBL), ... in Microbiology site by the American Society for ... program recognizes institutions and the scientists who worked ... the science of microbiology. A ceremony unveiling ... scheduled for Saturday, June 22, 2013, at 4:30 ...
Breaking Biology News(10 mins):UMass Amherst researchers develop powerful new technique to study protein function 2UMass Amherst researchers develop powerful new technique to study protein function 3Microbial diversity course designated as a 'Milestones in Microbiology' site 2
... Nov. 17, 2011   Life Technologies Corporation ... that the company has introduced its GeneArt® Algae ... and expression systems for photosynthetic microalgae Chlamydomonas ... strains are model organisms for the study of ...
... -- Researchers have demonstrated that the employees at ... fruits and vegetables and get 50 percent more exercise ... participating in the WellSteps Turnkey Wellness Solution ... and sleep quality. Employees also demonstrated fewer hospital and ...
... might be considered a "performance enhancing" substance for athletes, ... Journal ( http://www.fasebj.org ) shows that these enhancements ... in the brain. According to the study, short- ... constricting arteries, which reduces the flow of blood to ...
Cached Biology News:GeneArt® Algae Engineering Kits by Life Technologies™ 2GeneArt® Algae Engineering Kits by Life Technologies™ 3New Study Shows Impact of Employee Wellness Efforts 2Biker's warning! EPO hits blood vessels to raise blood pressure in the brain 2
(Date:6/20/2013)... (PRWEB) June 20, 2013 Conscires offer ... levels of interests and budgets., , ... on Scrum basics and the ScrumMaster role. In addition ... group activities and discussions on the necessary soft skills ... Scrum Team, and company-oriented Scrum implementation aspects. , ...
(Date:6/19/2013)... , June 19, 2013  U.S. Secretary of State ... at which distinguished Syngenta  scientist Mary-Dell Chilton ... 2013 World Food Prize. The prize is the foremost ... by improving the quality, quantity or availability of food ... other laureates were recognized for "revolutionary biotechnology discoveries that ...
(Date:6/19/2013)... -- Continuing its long history of proven clinical performance in ... Inc. announces the U.S. Food and Drug Administration (FDA) ... assay for use on its Access 2 immunoassay system. ... Coulter,s troponin I test for over 12 years ... to continue providing dependability to laboratories supporting emergency care," ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...
Breaking Biology Technology:Presenting Agile and Scrum Private Trainings in Kansas by Conscires Agile Practices 2Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3
... ST. LOUIS, Oct. 5 ISTO Technologies, Inc. (ISTO), ... regeneration, announced today the completion of patient enrollment in ... an injectable formulation of juvenile chondrocytes designed for the ... patients enrolled at two clinical sites. All patients enrolled ...
... Lake, N.Y. Given the many pressing concerns of the ... to lose sleep. But for those whose responsibility it is ... charged with that mission include scientists like medical researcher Steve ... develop a vaccine that will protect the public against weaponized ...
... (Nasdaq: AMGN ) today announced that results ... trials evaluating Vectibix® (panitumumab) in combination with chemotherapy (FOLFOX ... metastatic colorectal cancer (mCRC), respectively, were published online in ... "Both studies demonstrated that Vectibix administered with chemotherapy ...
Cached Biology Technology:ISTO Technologies, Inc., Completes Enrollment in Phase I NuQu Clinical Trial 2ISTO Technologies, Inc., Completes Enrollment in Phase I NuQu Clinical Trial 3Plague researchers race to beat bioterrorists 2Plague researchers race to beat bioterrorists 3Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 2Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 3Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 4Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 5Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 6Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 7Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 8Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 9Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 10Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 11
... trays and universal trays make vessel ... Shaking speed: 40 - ... amplitude Clamps for Erlenmeyer ... including Fernbach flasks Hinged ...
... SpliceArray is a new generation of microarrays ... Service enables you to rapidly elucidate alternatively ... be relevant for drug discovery. The service ... probe design and customized analysis with Agilents ...
... Machine is based on the simple, highefficiency ... Goryshin and Reznikoff, and by York et ... deletions and inversions by intramolecular transposition into ... vector. Although most researchers will be interested ...
... RC DC protein assay kit I provides reagents ... in the presence of reducing agents and detergents. ... assay. The kit includes reagents and standards sufficient ... I, 250 ml RC reagent II, 250 ml ...
Biology Products: